Age-related changes in midbrain dopaminergic regulation of the human reward system.
The dopamine system, which plays a crucial role in reward processing, is particularly vulnerable to aging. Significant losses over a normal lifespan have been reported for dopamine receptors and transporters, but very little is known about the neurofunctional consequences of this age-related dopaminergic decline. In animals, a substantial body of data indicates that dopamine activity in the midbrain is tightly associated with reward processing. In humans, although indirect evidence from pharmacological and clinical studies also supports such an association, there has been no direct demonstration of a link between midbrain dopamine and reward-related neural response. Moreover, there are no in vivo data for alterations in this relationship in older humans. Here, by using 6-[(18)F]FluoroDOPA (FDOPA) positron emission tomography (PET) and event-related 3T functional magnetic resonance imaging (fMRI) in the same subjects, we directly demonstrate a link between midbrain dopamine synthesis and reward-related prefrontal activity in humans, show that healthy aging induces functional alterations in the reward system, and identify an age-related change in the direction of the relationship (from a positive to a negative correlation) between midbrain dopamine synthesis and prefrontal activity. These results indicate an age-dependent dopaminergic tuning mechanism for cortical reward processing and provide system-level information about alteration of a key neural circuit in healthy aging. Taken together, our findings provide an important characterization of the interactions between midbrain dopamine function and the reward system in healthy young humans and older subjects, and identify the changes in this regulatory circuit that accompany aging.
Dreher
Jean-Claude
JC
Section on Integrative Neuroimaging, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. dreher@isc.cnrs.fr
Meyer-Lindenberg
Andreas
A
Kohn
Philip
P
Berman
Karen Faith
KF
D000328:Adult; D000367:Age Factors; D000368:Aged; D000375:Aging / Q000378:metabolism* / Q000502:physiology*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008636:Mesencephalon / Q000378:metabolism*; D008875:Middle Aged; D049268:Positron-Emission Tomography; D017397:Prefrontal Cortex / Q000502:physiology; D012201:Reward
C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine; D004298:Dopamine
Nat Neurosci. 2000 May;3(5):509-15
10769393
Nat Neurosci. 2007 Jun;10(6):787-91
17468751
Neurology. 1999 Oct 12;53(6):1212-8
10522875
Brain. 2005 Sep;128(Pt 9):1964-83
16049041
J Nucl Med. 1996 Apr;37(4):554-9
8691238
Trends Neurosci. 2007 May;30(5):220-7
17400299
Nat Rev Neurosci. 2003 Nov;4(11):863-72
14595398
Exp Brain Res. 2000 Jul;133(1):130-8
10933217
J Cogn Neurosci. 1999 Sep;11(5):511-20
10511640
Neurobiol Aging. 1998 Sep-Oct;19(5):437-45
9880046
J Neurosci. 1997 Aug 1;17(15):5972-8
9221793
Psychiatry Res. 1996 May 31;67(1):11-6
8797238
J Nucl Med. 2004 Jul;45(7):1135-45
15235059
Nat Neurosci. 2005 May;8(5):594-6
15821730
Nature. 2006 Aug 31;442(7106):1042-5
16929307
Neurobiol Aging. 1989 Jan-Feb;10(1):11-9
2569169
Annu Rev Neurosci. 2000;23:473-500
10845072
Neuroscience. 1981;6(2):177-87
6111765
Neurobiol Aging. 2000 Sep-Oct;21(5):683-8
11016537
Nature. 2003 Apr 10;422(6932):614-8
12687000
Brain Res Bull. 2005 Nov 15;67(5):382-90
16216684
Am J Psychiatry. 2000 Jan;157(1):75-80
10618016
Annu Rev Neurosci. 2007;30:259-88
17600522
Neuron. 2004 Jul 22;43(2):261-9
15260961
Nat Neurosci. 2002 Mar;5(3):267-71
11865311
Nat Rev Neurosci. 2000 Dec;1(3):199-207
11257908
Neuroimage. 1999 Jul;10(1):6-14
10385577
J Neurosci. 2001 Aug 15;21(16):RC159
11459880
Nature. 1999 Mar 4;398(6722):67-9
10078530
Science. 2003 Mar 21;299(5614):1898-902
12649484
J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
6822610
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19150-5
16380429
Neuroimage. 2001 Jan;13(1):161-75
11133319
Psychol Aging. 2002 Mar;17(1):85-100
11931290
Neuropharmacology. 2004;47 Suppl 1:3-13
15464121
Arch Gen Psychiatry. 1998 Apr;55(4):362-8
9554432
Nat Neurosci. 2005 Feb;8(2):147-8
15643429
Brain. 2002 Mar;125(Pt 3):584-94
11872615
Neuroreport. 2001 Dec 4;12(17):3683-7
11726774
Psychopharmacology (Berl). 1994 Oct;116(2):143-51
7862943
J Cereb Blood Flow Metab. 2005 Jul;25(7):807-19
15729292
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14504-9
14608034
Cereb Cortex. 2006 Apr;16(4):561-73
16033924
Psychopharmacology (Berl). 1991;103(1):41-5
1826059
J Cogn Neurosci. 2002 Aug 15;14(6):853-65
12191453
Nat Neurosci. 2007 Mar;10(3):376-84
17277774
J Cogn Neurosci. 2000 Jan;12(1):174-87
10769314